Search hospitals > Arizona > Tucson
University of Arizona Cancer Center-North Campus
Claim this profileTucson, Arizona 85719
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Pancreatic Cancer
Conducts research for Melanoma
491 reported clinical trials
53 medical researchers
Summary
University of Arizona Cancer Center-North Campus is a medical facility located in Tucson, Arizona. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Pancreatic Cancer, Melanoma and other specialties. University of Arizona Cancer Center-North Campus is involved with conducting 491 clinical trials across 511 conditions. There are 53 research doctors associated with this hospital, such as Holly E. Pariury, Pavani Chalasani, Rachna Shroff, M.D., and Aaron Scott, MD.Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
2Cancer
Global LeaderStage IV
Stage III
Stage I
Top PIs
Holly E. PariuryBanner University Medical Center - Tucson8 years of reported clinical research
Expert in Cancer
Expert in Brain Tumor
31 reported clinical trials
69 drugs studied
Pavani ChalasaniUniversity of Arizona Cancer Center2 years of reported clinical research
Expert in Breast Cancer
Studies Breast cancer
17 reported clinical trials
33 drugs studied
Rachna Shroff, M.D.University of Arizona Cancer Center6 years of reported clinical research
Studies Pancreatic Cancer
Studies Liver Cancer
15 reported clinical trials
33 drugs studied
Aaron Scott, MDUniversity of Arizona Cancer Center8 years of reported clinical research
Studies Colorectal Cancer
Studies Pancreatic Cancer
12 reported clinical trials
25 drugs studied
Clinical Trials running at University of Arizona Cancer Center-North Campus
Breast Cancer
Lung Cancer
Bladder Cancer
Kidney Cancer
Prostate Cancer
Cancer
Bladder Carcinoma
Lymphoma
Ovarian Cancer
Testicular cancer
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Arizona Cancer Center-North Campus?
University of Arizona Cancer Center-North Campus is a medical facility located in Tucson, Arizona. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Pancreatic Cancer, Melanoma and other specialties. University of Arizona Cancer Center-North Campus is involved with conducting 491 clinical trials across 511 conditions. There are 53 research doctors associated with this hospital, such as Holly E. Pariury, Pavani Chalasani, Rachna Shroff, M.D., and Aaron Scott, MD.
Where is University of Arizona Cancer Center-North Campus located?
The University of Arizona Cancer Center's North Campus is situated at 3838 N. Campbell Ave, Tucson, AZ 85719, at the northeast corner of North Campbell Avenue and East Allen Road. It is approximately 5 miles north of downtown Tucson via N Campbell Ave.
Who should I call to ask about financial aid or insurance network?
**University of Arizona Cancer Center-North Campus Financial Assistance and Insurance Information:**
- **Financial Assistance Department:** Contact the Office of Scholarships & Financial Aid at the University of Arizona via phone at 520-621-1858 or use the contact form for email inquiries.
- **Insurance Department:** For insurance-related inquiries, use the general contact form provided by the Arizona Cancer Center.
- **Payment and Treasury Services:** Contact the University of Arizona's Financial Services department at 520-621-9097 for payment services and at 520-621-7780 for treasury services.
What insurance does University of Arizona Cancer Center-North Campus accept?
The University of Arizona Cancer Center-North Campus accepts a wide range of insurance plans, including 2020 Medica Essential and Aetna APCN. The list of accepted insurance plans exceeds 395 options. Patients are advised to directly verify insurance information with the healthcare provider due to possible frequent changes.
What awards or recognition has University of Arizona Cancer Center-North Campus received?
The University of Arizona Cancer Center-North Campus, located in Tucson, Arizona, is an NCI-Designated Comprehensive Cancer Center. It is renowned for its significant contributions to cancer research and care. The center is involved in initiatives like the Cancer Moonshot℠, focusing on research benefiting Native Americans, and collaborates with Northern Arizona University to provide cancer screening and support to indigenous communities.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.